These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27248819)

  • 21. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
    Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
    J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA ploidy alterations detected during dedifferentiation of periosteal chondrosarcoma.
    Murata H; Kusuzaki K; Kuzuhara A; Takeshita H; Nakamura S; Tsuji Y; Hirasawa Y; Ashihara T
    Anticancer Res; 1999; 19(3B):2285-8. PubMed ID: 10472345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonality analysis and
    Yang T; Bai Y; Chen J; Sun K; Luo Y; Huang W; Zhang H
    J Bone Oncol; 2020 Jun; 22():100293. PubMed ID: 32742915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative Analysis.
    Hung YP; Diaz-Perez JA; Cote GM; Wejde J; Schwab JH; Nardi V; Chebib IA; Deshpande V; Selig MK; Bredella MA; Rosenberg AE; Nielsen GP
    Am J Surg Pathol; 2020 Sep; 44(9):1213-1223. PubMed ID: 32427623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
    Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
    Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
    Garcia-Dios DA; Lambrechts D; Coenegrachts L; Vandenput I; Capoen A; Webb PM; Ferguson K; ; Akslen LA; Claes B; Vergote I; Moerman P; Van Robays J; Marcickiewicz J; Salvesen HB; Spurdle AB; Amant F
    Gynecol Oncol; 2013 Feb; 128(2):327-34. PubMed ID: 23219661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case Report and Brief Literature Review on Dedifferentiated Chondrosarcoma in Proximal Phalanx: A Rare Location.
    Desai K; Liu S; Baskovich B; Makary R
    Cureus; 2022 Sep; 14(9):e29105. PubMed ID: 36249651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivating Mutations of RB1 and TP53 Correlate With Sarcomatous Histomorphology and Metastasis/Recurrence in Gastrointestinal Stromal Tumors.
    Merten L; Agaimy A; Moskalev EA; Giedl J; Kayser C; Geddert H; Schaefer IM; Cameron S; Werner M; Ströbel P; Hartmann A; Haller F
    Am J Clin Pathol; 2016 Dec; 146(6):718-726. PubMed ID: 28028119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma.
    Simbolo M; Vicentini C; Ruzzenente A; Brunelli M; Conci S; Fassan M; Mafficini A; Rusev B; Corbo V; Capelli P; Bria E; Pedron S; Turri G; Lawlor RT; Tortora G; Bassi C; Guglielmi A; Scarpa A
    Sci Rep; 2018 May; 8(1):7119. PubMed ID: 29740198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
    Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
    Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of PTEN deletions and mutations in multiple myeloma.
    Chang H; Qi XY; Claudio J; Zhuang L; Patterson B; Stewart AK
    Leuk Res; 2006 Mar; 30(3):262-5. PubMed ID: 16112193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia.
    Akizuki K; Sekine M; Kogure Y; Kameda T; Shide K; Koya J; Kamiunten A; Kubuki Y; Tahira Y; Hidaka T; Kiwaki T; Tanaka H; Sato Y; Kataoka H; Kataoka K; Shimoda K
    BMC Cancer; 2020 Jan; 20(1):5. PubMed ID: 31898539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumor.
    Oshrine BR; Olsen MN; Heneghan M; Wertheim G; Daber R; Wilmoth DM; Biegel JA; Pawel B; Aplenc R; King RL
    Cancer Genet; 2014 Apr; 207(4):153-9. PubMed ID: 24831771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
    Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
    Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A chimeric protein PTEN-L-p53 enters U251 cells to repress proliferation and invasion.
    Xiao M; An Y; Wang F; Yao C; Zhang C; Xin J; Duan Y; Zhao X; Fang N; Ji S
    Exp Cell Res; 2018 Aug; 369(2):234-242. PubMed ID: 29802838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Esophageal cancer in a family with hamartomatous tumors and germline PTEN frameshift and SMAD7 missense mutations.
    Sherman SK; Maxwell JE; Qian Q; Bellizzi AM; Braun TA; Iannettoni MD; Darbro BW; Howe JR
    Cancer Genet; 2015; 208(1-2):41-6. PubMed ID: 25554686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer.
    Schwaederle M; Daniels GA; Piccioni DE; Kesari S; Fanta PT; Schwab RB; Shimabukuro KA; Parker BA; Kurzrock R
    Cell Cycle; 2015; 14(11):1730-7. PubMed ID: 25928476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
    Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
    J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults.
    Jha P; Suri V; Singh G; Jha P; Purkait S; Pathak P; Sharma V; Sharma MC; Suri A; Gupta D; Mahapatra AK; Sarkar C
    Diagn Mol Pathol; 2011 Dec; 20(4):225-32. PubMed ID: 22089350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dedifferentiated chondrosarcoma revisited.
    Mavrogenis AF; Ruggieri P; Mercuri M; Papagelopoulos PJ
    J Surg Orthop Adv; 2011; 20(2):106-11. PubMed ID: 21838071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.